These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33852919)
21. The DISPARITY-II study: delays to antibiotic administration in women with severe sepsis or septic shock. Madsen TE; Napoli AM Acad Emerg Med; 2014 Dec; 21(12):1499-502. PubMed ID: 25424151 [TBL] [Abstract][Full Text] [Related]
22. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial. Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M; JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483 [TBL] [Abstract][Full Text] [Related]
23. Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial. Ware LB; Files DC; Fowler A; Aboodi MS; Aggarwal NR; Brower RG; Chang SY; Douglas IS; Fields S; Foulkes AS; Ginde AA; Harris ES; Hendey GW; Hite RD; Huang W; Lai P; Liu KD; Thompson BT; Matthay MA; JAMA; 2024 Aug; 332(5):390-400. PubMed ID: 38762798 [TBL] [Abstract][Full Text] [Related]
24. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial. Lyu QQ; Zheng RQ; Chen QH; Yu JQ; Shao J; Gu XH Crit Care; 2022 Sep; 26(1):295. PubMed ID: 36171582 [TBL] [Abstract][Full Text] [Related]
25. Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. Papazian L; Roch A; Charles PE; Penot-Ragon C; Perrin G; Roulier P; Goutorbe P; Lefrant JY; Wiramus S; Jung B; Perbet S; Hernu R; Nau A; Baldesi O; Allardet-Servent J; Baumstarck K; Jouve E; Moussa M; Hraiech S; Guervilly C; Forel JM; JAMA; 2013 Oct; 310(16):1692-700. PubMed ID: 24108510 [TBL] [Abstract][Full Text] [Related]
27. Enteral nutrition is associated with improved outcome in patients with severe sepsis. A secondary analysis of the VISEP trial. Elke G; Kuhnt E; Ragaller M; Schädler D; Frerichs I; Brunkhorst FM; Löffler M; Reinhart K; Weiler N; Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):223-33. PubMed ID: 23455443 [TBL] [Abstract][Full Text] [Related]
28. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P; Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411 [TBL] [Abstract][Full Text] [Related]
29. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E; N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185 [TBL] [Abstract][Full Text] [Related]
30. Initial levels of organ failure, microbial findings and mortality in intensive care-treated primary, secondary and tertiary sepsis. Castegren M; Jonasson M; Castegren S; Lipcsey M; Sjölin J Crit Care Resusc; 2015 Sep; 17(3):174-81. PubMed ID: 26282255 [TBL] [Abstract][Full Text] [Related]
31. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Dhainaut JF; Tenaillon A; Hemmer M; Damas P; Le Tulzo Y; Radermacher P; Schaller MD; Sollet JP; Wolff M; Holzapfel L; Zeni F; Vedrinne JM; de Vathaire F; Gourlay ML; Guinot P; Mira JP Crit Care Med; 1998 Dec; 26(12):1963-71. PubMed ID: 9875905 [TBL] [Abstract][Full Text] [Related]
32. A randomised trial of Sehgal IS; Guleria R; Singh S; Siddiqui MS; Agarwal R ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34031642 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952 [TBL] [Abstract][Full Text] [Related]
34. Severe sepsis and septic shock in patients with pre-existing non-cardiac pulmonary hypertension: contemporary management and outcomes. Tsapenko MV; Herasevich V; Mour GK; Tsapenko AV; Comfere TB; Mankad SV; Cartin-Ceba R; Gajic O; Albright RC Crit Care Resusc; 2013 Jun; 15(2):103-9. PubMed ID: 23931041 [TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Dhainaut JF; Tenaillon A; Le Tulzo Y; Schlemmer B; Solet JP; Wolff M; Holzapfel L; Zeni F; Dreyfuss D; Mira JP Crit Care Med; 1994 Nov; 22(11):1720-8. PubMed ID: 7956274 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Effect of Probiotics on Cytokine Levels in Critically Ill Children With Severe Sepsis: A Double-Blind, Placebo-Controlled Trial. Angurana SK; Bansal A; Singhi S; Aggarwal R; Jayashree M; Salaria M; Mangat NK Crit Care Med; 2018 Oct; 46(10):1656-1664. PubMed ID: 29957709 [TBL] [Abstract][Full Text] [Related]
37. A pilot study on the melatonin treatment in patients with early septic shock: results of a single-center randomized controlled trial. Taher A; Shokoohmand F; Abdoli E; Mohammadi Y; Mehrpooya M Ir J Med Sci; 2022 Aug; 191(4):1913-1924. PubMed ID: 34468959 [TBL] [Abstract][Full Text] [Related]
38. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Pontes-Arruda A; Aragão AM; Albuquerque JD Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002 [TBL] [Abstract][Full Text] [Related]
39. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437 [TBL] [Abstract][Full Text] [Related]
40. [The organ protective effects and timing of continuous blood purification in the treatment of severe sepsis:a double-blind randomized controlled trial]. Zhou R; Weng F; Dai W; Yan J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):241-5. PubMed ID: 29917338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]